MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the ...
FDA Authorization of Flavored Zyn Products Ignores Appeal to Kids and Risks Another Juul
The FDA today has set a dangerous precedent that puts the nation's kids at risk by authorizing the sale of 20 Zyn nicotine ...
FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Illuccix® Receives European Approval
Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug ...
Carl Zeiss Meditec AG: ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with ...
Needham’s top stocks for 2025: AX, CYBR, CART and more
Discover the top stocks for the new year selected by Needham analysts, including ACV Auctions, Alcon, Alegro Microsystems, ...
Finanznachrichten4d
icotec Medical, Inc.: icotec Announces FDA clearance for Spinal Infection Indication with BlackArmor Implants
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
Daily Caller on MSN1d
Trump-Appointed Judge Allows Several States To Continue Abortion Pill Challenge
A Texas federal judge Thursday ruled Idaho, Kansas and Missouri can join a case challenging access to the abortion pill. Trump-appointed Judge Matthew Kacsmaryk allowed the states to pursue legal ...
Hosted on MSN1d
EXCLUSIVE: Pro-Life Doctors Urge Incoming Trump Admin To Put Abortion Pills Under The Microscope
Action sent a letter Friday to GOP officials urging them to question President-elect Donald Trump’s nominees about their ...
Medindia3d
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT® Test for DCIS Breast Cancer Patients
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...